News and Publications
Latest News
In the CCIV 2023 Year in Review Newsletter, Dr. Satoshi Kamidani is featured on page 6 for leading the newly awarded CDC contract for the CISA Project.
Link to CCIV 2023 Year in Review
Emory Children's Center- Vaccine Research Clinic is featured on page 33 for participation in the clinical trial leading to U.S. FDA approval of an immunization for respiratory syncytial virus (RSV) infections.
Link to CHOA and Emory 2023 Research Report
The Emory Children's Center - Vaccine Research Clinic was a site for the Mix-and-Match study for COVID-19 vaccines, which was featured in the Emory University News in early 2022.
Link to Emory News Center article
Emory Children's Center - Vaccine Research Clinic was featured in the Spring 2022 issue of Emory Medicine Magazine highlighting our young volunteers participating in children's COVID-19 vaccine research studies.
Link to Emory Medicine Magazine article
Publications
Below are publications that we want to highlight
Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age
The KidCOVE study demonstrated mRNA-1273 COVID-19 vaccine effectiveness in children 6 months to 5 years of age.
Read the ArticleFunctional Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants in Children...
SARS-CoV-2 infection and vaccination elicits functional neutralizing and ADCC antibodies in children.
Read the ArticleEvaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age.
The KidCOVE study demonstrated mRNA-1273 COVID-19 vaccine effectiveness in children 6 to 11 years of age.
Read the ArticleBNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood...
COVID-19 vaccination reduces the risk of MIS-C in children 5-18 years of age.
Read the ArticleMaternal Vaccination and Risk of Hospitalization for Covid-19 among Infants
Maternal immunization with COVID-19 vaccination reduces risk of COVID-19 in infants.
Read the ArticleHomologous and Heterologous Covid-19 Booster Vaccinations
Heterologous COVID-19 booster vaccinations are safe and immunogenic.
Read the ArticleEffectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents
COVID-19 vaccination is effective in preventing critical illness from COVID-19 in adolescents.
Read the ArticleDistinguishing Multisystem Inflammatory Syndrome in Children From COVID-19...
Clinical and laboratory features differentiate MIS-C from similar clinical syndromes.
Read the ArticleA Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness...
Influenza vaccinations are effective in preventing hospitalizations in children.
Read the ArticleThe Importance of Advancing Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Children
We were early advocates for the development of safe and effective COVID-19 vaccinations for children.
Read the ArticleSafety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
mRNA-1273 COVID-19 vaccine was safe and immunogenic in older adults.
Read the ArticleAn mRNA Vaccine against SARS-CoV-2 - Preliminary Report
We participated in the first phase 1 clinical trial of mRNA-1273 COVID-19 vaccination, that paved the way for phase 3 trials, licensure, and approval.
Read the Article